Most patients start to see the scale move after 24 weeks, especially as their dose is increased to a therapeutic level
Winner: tirzepatide / Zepbound Round 3: Side Effects All GLP-1 medications have similar side effects
Saida T, Miyazaki A, Oguchi S, Ishihara Y, Yamazaki Y, Murase S, Yoshikawa S, Tsuchida T, Kawabata Y, Tamaki K: Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan
Some observational data suggest weight loss from GLP-1 use may indirectly improve metabolic markers in patients with both Hashimoto's and obesity
The 0.76 percentage point reduction in HbA 1c level in the current study is higher or similar to that observed with other antidiabetic medicines, such as pioglitazone (0.2 percentage points) 29 and dapagliflozin (0.58-0.89 percentage points)
While this has not been definitively shown in humans, the concern remains